Cost of Revenue in USD of ABVC BIOPHARMA, INC. from 2014 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Abvc Biopharma, Inc. quarterly/annual Cost of Revenue history and change rate from 2014 to Q4 2024.
  • Abvc Biopharma, Inc. Cost of Revenue for the quarter ending December 31, 2024 was $0.000, a 100% decline year-over-year.
  • Abvc Biopharma, Inc. Cost of Revenue for the twelve months ending December 31, 2024 was $763.000, a 99.7% decline year-over-year.
  • Abvc Biopharma, Inc. annual Cost of Revenue for 2024 was $763.000, a 99.7% decline from 2023.
  • Abvc Biopharma, Inc. annual Cost of Revenue for 2023 was $302K, a 5.45% increase from 2022.
  • Abvc Biopharma, Inc. annual Cost of Revenue for 2022 was $286K, a 5531% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Change (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Change (%)

ABVC BIOPHARMA, INC. Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $763 $0 -$139K -100% Oct 1, 2024 Dec 31, 2024 10-K 2025-04-15
Q3 2024 $140K $296 -$29.3K -99% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-03
Q2 2024 $169K $190 -$72.8K -99.7% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-13
Q1 2024 $242K $277 -$60K -99.5% Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-30
Q4 2023 $302K $139K -$126K -47.6% Oct 1, 2023 Dec 31, 2023 10-K 2025-04-15
Q3 2023 $428K $29.6K +$18.9K +176% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $409K $73K +$64.6K +772% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $345K $60.2K +$58.3K +3077% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-17
Q4 2022 $286K $265K +$263K +9372% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $23.8K $10.7K +$10.3K +2633% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-15
Q2 2022 $13.5K $8.37K +$7.72K +1195% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $5.74K $1.9K +$651 +52.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $5.09K $2.8K +$900 +47.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $4.19K $393 -$8.23K -95.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $12.4K $646 -$3.59K -84.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $16K $1.25K -$2.71K -68.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $18.7K $1.9K -$587 -23.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $19.3K $8.62K +$5.82K +208% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $13.5K $4.24K -$9.12K -68.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $22.6K $3.96K +$2.46K +164% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $20.1K $2.49K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 $2.8K +$2.26K +421% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-17
Q2 2019 $13.4K +$11K +476% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $1.5K Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-29
Q3 2018 $537 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-18
Q2 2018 $2.32K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2016 $32.00 Jan 1, 2016 Mar 31, 2016 10-Q/A 2018-03-19
Q3 2014 $0 Sep 19, 2014 Sep 30, 2014 10-K 2015-11-27

ABVC BIOPHARMA, INC. Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $763 -$301K -99.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-15
2023 $302K +$15.6K +5.45% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-15
2022 $286K +$281K +5531% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 $5.09K -$13.6K -72.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $18.7K -$1.42K -7.06% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $20.1K -$165K -89.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 $185K Jan 1, 2018 Dec 31, 2018 10-K 2020-05-15
2016 $32.00 -$489 -93.9% Oct 1, 2015 Sep 30, 2016 10-KT 2018-04-13
2015 $521 +$521 Oct 1, 2014 Sep 30, 2015 10-K 2015-11-27
2014 $0 Oct 1, 2013 Sep 18, 2014 10-K 2015-11-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.